Study: Alcohol-related cirrhosis patients are sicker, costlier and often female

Alcohol is a major contributor to cirrhosis cases — and women drinkers are disproportionately affected

Author | Shantell M. Kirkendoll

Among that group, 294,215 people had cirrhosis; 105,871 (36 percent) had alcohol-related cirrhosis. The latter group was sicker and admitted or readmitted to a hospital more often, incurring nearly twice the health care costs per person: $44,835 versus $23,329.

“When I look at this data, it tells me that this is a big problem,” says Jessica Mellinger, M.D., a Michigan Medicine gastroenterologist and health services researcher at the Institute for Healthcare Policy & Innovation.

And it could be a particularly big problem for women, who in recent years have been diagnosed with alcohol use disorders at a rate nearly twice that of men.

Mellinger’s study, published in the journal Hepatology, found that women showed a 50 percent increase in alcohol-related cirrhosis during that seven-year period; men showed a 30 percent increase.

Although biology doesn’t explain why women appear to be consuming more alcohol then they used to, it does shed light on the effects.

“Women process alcohol differently than men and they are more susceptible to damage in the liver than men,” says Mellinger. “They can develop cirrhosis with less alcohol and in a shorter time frame. The hypothesis is that certain hormones make women more susceptible, though we don’t know exactly why they are so much more susceptible.”

A costly, widespread issue

To conduct their study, Mellinger and her team examined privately insured individuals ages 18 to 64 by using the Truven MarketScan Commercial Claims and Encounters database. It is the largest dataset of claims for people with private insurance obtained through their employers.

The study’s goal was to determine the prevalence, health-care utilization and costs of alcohol-related cirrhosis among privately insured people in the United States. The research showed:

  • Patients with alcohol-related cirrhosis aren’t uncommon. The figures nearly surpass those of some common cancers.
  • Health care for these patients is costly, sometimes as much as the cost for cancer patients.
  • Cirrhosis has already progressed when many patients see a doctor for symptoms, preventing a chance for early diagnosis and treatment.

But it only looked at one segment of the population.

“At the time we did this study, we also considered using data sets from Medicare and Medicaid, but they were restricting reporting of claims related to substance abuse, and we knew we’d be missing information,” says Mellinger.

Since that time, the Centers for Medicare and Medicaid Services began reporting substance abuse; that information is now open to researchers. Mellinger expects alcohol-related cirrhosis statistics to increase significantly after that patient data is reviewed.

The reason: “Many people with [alcohol-related cirrhosis] are too sick to remain employed, so more of these patients are insured through government-sponsored insurance such as Medicare and Medicaid,” she says, noting that another limitation of the study was a lack of information about race and ethnic groups.

Alcohol-use treatment programs vital

Prior research has shown that there is no ethical justification for deprioritizing patients from receiving a transplant because they have alcohol-related liver disease.

“But first they will need alcohol cessation treatment before they can be transplanted with success,” says Mellinger. “Alcohol-use treatment is effective and many patients do stop drinking, obtain transplant and do well afterward.”

Although there is stigma to alcohol-related cirrhosis, it is common and it’s not a moral failure, she adds. “Many people in the medical community think that alcohol use is not treatable, but it is. There is a lot of collaboration at U-M to provide the right help for patients with alcohol-related liver disease.”

Getting that help is crucial: When patients have advanced liver disease, the only action that affects whether they live or die is if they stop drinking.

“Once you have cirrhosis, or scar tissue on the liver, it’s permanent,” says Mellinger, who works closely with the University of Michigan psychiatry department and the University of Michigan Addiction Treatment Services. “But even though the damage is still there, your liver function can improve dramatically” if you stop drinking.

Set to embark on further study with all insurance payers, Mellinger hopes her current work will help physicians better understand that alcohol-related cirrhosis is a growing problem that demands attention and resources.

“We’re only touching the tip of the iceberg,” she says. “By demonstrating that alcohol-related cirrhosis is a high-burden health care problem that could be prevented, we hope that it will increase funding for early detection of alcohol use and for greater utilization of alcohol-use treatment programs.”

University of Michigan Addiction Treatment Services offers a broad array of services, including a recovery program for health care workers who battle alcohol and substance addiction.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories Illustration of three older women playing cards at a table
Health Lab
Research needed on support for nontraditional caregivers providing care for people with Alzheimer’s disease and related dementias
A growing number of people living with Alzheimer’s disease and related dementias – especially those from diverse backgrounds – receive care from a network of individuals that increasingly includes nontraditional informal caregivers.
Aerial view of University of Michigan Health hospital in Ann Arbor, Michigan.
News Release
University of Michigan Health purchases land in Troy for new clinical facility
University of Michigan Health will purchase 7.28 acres of vacant land at the former Kmart headquarters location. U-M Health plans to build a multi-specialty facility on the property to expand specialty clinical services and increase patient access to the Oakland County region
Headshot of Shahzad Mian, M.D.
News Release
Michigan Medicine names new chair of Department of Ophthalmology and Visual Sciences
Shahzad I. Mian, M.D., has been appointed chair of the Department of Ophthalmology and Visual Sciences and the F. Bruce Fralick Professor of Ophthalmology in the Medical School and the Director of the W.K. Kellogg Eye Center
George Mashour, M.D., Ph.D. standing in front of a bookcase, smiling. He is wearing a dark suit, white shirt, dark striped tie and dark framed glasses.
News Release
George Mashour, M.D., Ph.D. appointed senior associate dean for faculty and faculty development
George A. Mashour, M.D., Ph.D., has been appointed senior associate dean for faculty and faculty development of the University of Michigan Medical School by the U-M Board of Regents, effective May 1, 2024.
c.s_mott_childrens_hospital
News Release
$5.4M pediatric emergency services fast track clinic to serve lower acuity cases
University of Michigan Health C.S. Mott Children’s Hospital plans to build a $5.4 million emergency services fast track clinic to treat children, teens and young adults with lower acuity conditions.
Close up image of red blood cells moving through veins
Health Lab
Discovery reveals how this common stinky gas is processed to promote blood vessel growth
A new collaborative study, examined the interaction between three naturally occurring gases — nitric oxide (NO), oxygen, and H2S — during generation of new blood vessels, called angiogenesis.